3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Pleural Effusion, Malignant
1
Pinealoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Meningioma
1
Medulloblastoma
1
Gliosarcoma
1
Glioma, Subependymal
1
Glioblastoma
1
Familial ependymoma
1
Ependymoma
1
Craniopharyngioma
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
aldesleukin
2
Trastuzumab
2
Pharmaceutical Preparations
2
Interleukin-2
2
Carboplatin
2
Bevacizumab
2
tocilizumab
1
tipifarnib
1
romidepsin
1
lipoplatin
1
Verteporfin
1
Valacyclovir
1
Tyrosine Kinase Inhibitors
1
Sorafenib
1
SPI-77, liposomal
1
Povidone-Iodine
1
Pleurodesis
1
Photochemotherapy
1
Paclitaxel
1
LMB-100
1
Interleukin-12 Subunit p35
1
Interleukin-12
1
Immunotherapy, Adoptive
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Docetaxel
1
Decitabine
1
Dasatinib
1
Cytoreduction Surgical Procedures
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Pleural Effusion, Malignant
×
Verteporfin
×
Clear all
NCT02702700
2019-03-20
PDT-lipo
Centre Hospitalier Universitaire Vaudois
Phase 1
Terminated
1 enrolled